HTA: positive phase IIb results for firibastat, a new anti-hypertensive drug with brain function (Cardio Online – french only))
Quantum Genomics’ brain-targeting blood pressure drug meets phase 2b endpoints (FierceBiotech)
ITW Integral Exchange Monday, November 12 – Quantum Genomics at 00:52:00 (BFM TV – french only))
Jean-Philippe Milon: Quantum Genomics will sign a partnership in less than 18 months (Le Revenu TV – french only)
Quantum Genomics: conclusive clinical trial in hypertension (Romandie – french only)
Quantum Genomics: Positive signals and a scrap value. (The Investing Echoes – french only)
Quantum Genomics: Jean-Philippe Milon General Manager Quantum Genomics: “We have set ourselves the goal of signing a partnership in the next 24 months”. Strategy and investment prospects of the specialist Biotech. (The Stock Market and Life – french only)
Quantum Genomics strengthens its scientific committee with the appointment of Professor Frans Leenen, renowned expert in heart failure (Le Figaro Economie – french only)
Quantum Genomics Wins Galen MedStartUp Award for “Best Innovative Clinical Study Design” (BFM Business – french only)
Philippe Croizon makes the leap with RTL for cardiovascular diseases (RTL – french only)